Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Meseonznik

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
STAR Protocols|July 22, 2025
Protocol for differential analysis of pseudouridine modifications using nanopore DRS and unmodified transcriptome controlOleksandra Fanari, Michele Meseonznik, Dylan Bloch, et al.
RNA (New York, N.Y.)|July 9, 2025
Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized statesOleksandra Fanari, Dylan Bloch, Yuchen Qiu, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
mRNA psi profiling using nanopore DRS reveals cell type-specific pseudouridylationCaroline A McCormick, Michele Meseonznik, Yuchen Qiu, et al.
Research Square|June 29, 2026
High-Rate Fingerprinting of Protein Isoforms by Quasi-regulated Enzyme-free Transport Through CytK NanoporesMeni Wanunu, Amr Makhamreh, Ali Fallahi, et al.
Cell Systems|March 21, 2025
Probing enzyme-dependent pseudouridylation using direct RNA sequencing to assess epitranscriptome plasticity in a neuronal cell lineOleksandra Fanari, Sepideh Tavakoli, Yuchen Qiu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Probing enzyme-dependent pseudouridylation using direct RNA sequencing to assess neuronal epitranscriptome plasticityOleksandra Fanari, Sepideh Tavakoli, Yuchen Qiu, et al.
Nucleic Acids Research|April 21, 2026
Multimodal profiling reveals cell type-specific pseudouridine modification and density-dependent translational regulationCaroline A McCormick, Michele Meseonznik, Yuchen Qiu, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
STAR Protocols|July 22, 2025
Protocol for differential analysis of pseudouridine modifications using nanopore DRS and unmodified transcriptome controlOleksandra Fanari, Michele Meseonznik, Dylan Bloch, et al.
RNA (New York, N.Y.)|July 9, 2025
Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized statesOleksandra Fanari, Dylan Bloch, Yuchen Qiu, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
mRNA psi profiling using nanopore DRS reveals cell type-specific pseudouridylationCaroline A McCormick, Michele Meseonznik, Yuchen Qiu, et al.
Research Square|June 29, 2026
High-Rate Fingerprinting of Protein Isoforms by Quasi-regulated Enzyme-free Transport Through CytK NanoporesMeni Wanunu, Amr Makhamreh, Ali Fallahi, et al.
Cell Systems|March 21, 2025
Probing enzyme-dependent pseudouridylation using direct RNA sequencing to assess epitranscriptome plasticity in a neuronal cell lineOleksandra Fanari, Sepideh Tavakoli, Yuchen Qiu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Probing enzyme-dependent pseudouridylation using direct RNA sequencing to assess neuronal epitranscriptome plasticityOleksandra Fanari, Sepideh Tavakoli, Yuchen Qiu, et al.
Nucleic Acids Research|April 21, 2026
Multimodal profiling reveals cell type-specific pseudouridine modification and density-dependent translational regulationCaroline A McCormick, Michele Meseonznik, Yuchen Qiu, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Pageof 1